Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Balances at Dec. 31, 2019	$ 1,727	$ 95,032,252	$ (86,935,593)	$ 177,385	$ 8,275,771
Balances (in Shares) at Dec. 31, 2019	17,270,848
Modification of warrants issued with debt		95,223			95,223
Sale of common stock for cash	$ 12	199,988			200,000
Sale of common stock for cash (in Shares)	114,719
Stock-based compensation	$ 15	741,653			741,668
Stock-based compensation (in Shares)	150,000
Issuance of common stock to settle accounts payable		8,270			8,270
Issuance of common stock to settle accounts payable (in Shares)	3,540
Warrant exercise for cash	$ 73	1,248,910			1,248,983
Warrant exercise for cash (in Shares)	727,107
Warrant exercise inducement		366,795			366,795
Net loss			(9,217,108)		(9,217,108)
Foreign currency translation				(6,972)	(6,972)
Balances at Sep. 30, 2020	$ 1,827	97,693,091	(96,152,701)	170,413	1,712,630
Balances (in Shares) at Sep. 30, 2020	18,266,214
Balances at Jun. 30, 2020	$ 1,822	97,581,421	(94,234,462)	141,356	3,490,137
Balances (in Shares) at Jun. 30, 2020	18,221,807
Warrant and stock cashless exercises	$ 5	(5)
Warrant and stock cashless exercises (in Shares)	44,407
Stock-based compensation		111,675			111,675
Net loss			(1,918,239)		(1,918,239)
Foreign currency translation				29,057	29,057
Balances at Sep. 30, 2020	$ 1,827	97,693,091	(96,152,701)	170,413	1,712,630
Balances (in Shares) at Sep. 30, 2020	18,266,214
Balances at Dec. 31, 2020	$ 1,964	102,651,304	(98,234,151)	160,642	4,579,759
Balances (in Shares) at Dec. 31, 2020	19,642,401
Sale of common stock for cash	$ 164	10,282,834			10,282,998
Sale of common stock for cash (in Shares)	1,642,856
Stock-based compensation		4,795,069			4,795,069
Settlement of accrued expense with stock options		349,376			349,376
Convertible notes converted to common stock	$ 117	6,232,223			6,232,340
Convertible notes converted to common stock (in Shares)	1,171,296
Stock option exercise for cash	$ 1	24,659			$ 24,660
Stock option exercise for cash (in Shares)	4,802				504,804
Warrant exercise for cash	$ 6	273,747			$ 273,753
Warrant exercise for cash (in Shares)	60,834
Cashless stock option exercise	$ 40	(40)
Cashless stock option exercise (in Shares)	412,569
Cashless warrant exercise	$ 27	(27)
Cashless warrant exercise (in Shares)	263,661
Net loss			(10,746,514)		(10,746,514)
Foreign currency translation				60,991	60,991
Balances at Sep. 30, 2021	$ 2,319	124,609,145	(108,980,665)	221,633	15,852,432
Balances (in Shares) at Sep. 30, 2021	23,198,419
Balances at Jun. 30, 2021	$ 2,137	111,493,973	(103,781,760)	202,667	7,917,017
Balances (in Shares) at Jun. 30, 2021	21,363,027
Sale of common stock for cash	$ 164	10,282,834			10,282,998
Sale of common stock for cash (in Shares)	1,642,856
Stock-based compensation		2,533,943			2,533,943
Stock option exercise for cash	$ 1	24,659			24,660
Stock option exercise for cash (in Shares)	4,802
Warrant exercise for cash	$ 6	273,747			273,753
Warrant exercise for cash (in Shares)	60,834
Cashless stock option exercise	$ 11	(11)
Cashless stock option exercise (in Shares)	125,998
Cashless warrant exercise
Cashless warrant exercise (in Shares)	902
Net loss			(5,198,905)		(5,198,905)
Foreign currency translation				18,966	18,966
Balances at Sep. 30, 2021	$ 2,319	$ 124,609,145	$ (108,980,665)	$ 221,633	$ 15,852,432
Balances (in Shares) at Sep. 30, 2021	23,198,419